Prevalence of Bacteroides and Prevotella spp. in ulcerative colitis

Journal of Medical Microbiology

Volumn 55, Issue 5, 2006, Pages 617-624

  Lucke, Katja ^a   Miehlke, Stephan ^b   Jacobs, Enno ^c   Schuppler, Markus ^d  

^a LUZERNER KANTONSSPITAL   (Switzerland)

^b UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^d ETH ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; RNA 16S;

ARTICLE; BACTERIUM IDENTIFICATION; BACTEROIDES; COLON BIOPSY; COLON MUCOSA; COLONOSCOPY; CONTROLLED STUDY; GENE SEQUENCE; HUMAN; HUMAN TISSUE; INTESTINE FLORA; MAJOR CLINICAL STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PREVOTELLA; PRIORITY JOURNAL; ULCERATIVE COLITIS;

BACTEROIDES; BIOPSY; COLITIS, ULCERATIVE; COLONOSCOPY; DNA, BACTERIAL; DNA, RIBOSOMAL; HUMANS; INTESTINAL MUCOSA; MOLECULAR SEQUENCE DATA; PREVOTELLA; RNA, RIBOSOMAL, 16S; SEQUENCE ANALYSIS, DNA;

EID: 33646241058     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.46198-0     Document Type: Article

References (48)

1. Amann, R. I., Ludwig, W. & Schleifer, K.-H. (1995). Phylogenetic identification and in situ detection of individual microbial cells without cultivation. Microbiol Rev 59, 143-169.
2. Barcenilla, A., Pryde, S. E., Martin, J. C., Duncan, S. H., Stewart, C. S., Henderson, C. & Flint, H. J. (2000). Phylogenetic relationships of butyrate-producing bacteria from the human gut. Appl Environ Microbiol 66, 1654-1661.
3. Berg, R. D. (1996). The indigenous gastrointestinal microflora. Trends Microbiol 4, 430-435.
4. Blumberg, R. S., Saubermann, L. J. & Strober, W. (1999). Animal models of mucosal inflammation and their relation to human inflammatory bowel disease. Curr Opin Immunol 11, 648-656.
5. Breeling, J. L., Onderdonk, A. B., Cisneros, R. L. & Kasper, D. L. (1988). Bacteroides vulgatus outer membrane antigens associated with carrageenan-induced colitis in guinea pigs. Infect Immun 56, 1754-1759.
6. Campirei, M. & Gionchetti, P. (2001). Bacteria as the cause of ulcerative colitis. Gut 48, 132-135.
7. Chapman, R. W., Selby, W. S. & Jewell, D. P. (1986). Controlled trial of intravenous metronidazole as an adjunct to corticosteroids in severe ulcerative colitis. Gut 27, 1210-1212.
8. Dianda, L., Hanby, A. M., Wright, N. A., Sebesteny, A., Hayday, A. C. & Owen, M. J. (1997). T cell receptor-αβ-deficient mice fail to develop colitis in the absence of a microbial environment. Am J Pathol 150, 91-97.
9. Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S. R., Nelson, K. E. & Relman, D. A. (2005). Diversity of the human intestinal microbial flora. Science 308, 1635-1638.
10. Ell, C., Fischbach, W., Keller, R., Dehe, M., Mayer, G., Schneider, B., Albrecht, U. & Schuette W.; Hintertux Study Group (2003). A randomized, blinded, prospective trial to compare the safety and efficacy of three bowel-cleansing solutions for colonoscopy (HSG-01*). Endoscopy 35, 300-304.
11. Fenner, L., Roux, V., Mallet, M.-N. & Raoult, D. (2005). Bacteroides massiliensis sp. nov., isolated from blood culture of a newborn. Int J Syst Evol Microbiol 55, 1335-1337.
12. Fiocchi, C. (1998). Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 115, 182-205.
13. Garcia-Lafuente, A., Antolin, M., Guarner, F. & 8 other authors (1997). Incrimination of anaerobic bacteria in the induction of experimental colitis. Am J Physiol 272, G10-G15.
14. Greenbloom, S. L., Steinhart, A. H. & Greenberg, G. R. (1998). Combination ciprofloxacin and metronidazole for active Crohn's disease. Can J Gastroenterol 12, 53-56.
15. Hartley, M. G., Hudson, M. J., Swarbrick, E. T., Hill, M. J., Gent, A. E., Hellier, M. D. & Grace, R. H. (1992). The rectal mucosa-associated microflora in patients with ulcerative colitis. J Med Microbiol 36, 96-103.
16. Hold, G. L., Pryde, S. E., Russell, V. J., Furrie, E. & Flint, H. J. (2002). Assessment of microbial diversity in human colonic samples by 16S rDNA sequence analysis. FEMS Microbiol Ecol 39, 33-39.
17. Hooper, L. V. & Gordon, J. I. (2001). Commensal host-bacterial relationships in the gut. Science 292, 1115-1118.
18. Hooper, L. V., Wong, M. H., Thelin, A., Hansson, L., Falk, P. G. & Gordon, J. I. (2001). Molecular analysis of commensal host-microbial relationships in the intestine. Science 291, 881-884.
19. Leser, T. D., Amenuvor, J. Z., Jensen, T. K., Lindecrona, R. H., Boye, M. & Møller, K. (2002). Culture-independent analysis of gut bacteria: the pig gastrointestinal tract microbiota revisited. Appl Environ Microbiol 68, 673-690.
20. Macpherson, A., Khoo, U. Y., Forgacs, I., Philpott-Howard, J. & Bjarnason, I. (1996). Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria. Gut 38, 365-375.
21. Manz, W., Amann, R., Ludwig, W. & Schleifer, K.-H. (1996). Application of a suite of 16S rRNA-specific oligonucleotide probes designed to investigate bacteria ol the phylum Cytophaga-Flavobacter-Bacteroides in the natural environment. Microbiology 142, 1097-1106.
22. Marchesi, J. R., Sato, T., Weightman, A. J., Martin, T. A., Fry, J. C., Hiom, S. J. & Wade, W. G. (1998). Design and evaluation of useful bacterium-specific PCR primers that amplify genes coding for bacterial 16S rRNA. Appl Environ Microbiol 64, 795-799.
23. Marks, C. G., Hawley, P. R., Peach, S. L., Drasar, B. S. & Hill, M. J. (1979). The effects of phthalylsulphathiazole on the bacteria of the colonic mucosa and intestinal contents as revealed by the examination of surgical samples. Scand J Gastroenterol 14, 891-896.
24. Mishina, D., Katsel, P., Brown, S. T., Gilberts, E. C. A. M. & Greenstein, R. J. (1996). On the etiology of Crohns disease. Proc Natl Acad Sci U S A 93, 9816-9820.
25. Onderdonk, A. B., Hermos, J. A., Dzink, J. L. & Bartlett, J. G. (1978). Protective effect of metronidazole in experimental ulcerative colitis. Gastroenterology 74, 521-526.
26. Onderdonk, A. B., Cisneros, R. L. & Bronson, R. T. (1983). Enhancement of experimental ulcerative colitis by immunization with Bacteroides vulgatus. Infect Immun 42, 783-788.
27. Ott, S. J., Musfeldt, M., Wenderoth, D. F., Hampe, J., Brant, O., Fölsch, U. R., Timmis, K. N. & Schreiber, S. (2004). Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut 53, 685-693.
28. Papadakis, K. A. & Targan, S. R. (1999). Current theories on the causes of inflammatory bowel disease. Gastroenterol Clin North Am 28, 283-296.
29. Prantera, C., Berto, E., Scribano, M. L. & Falasco, G. (1998). Use of antibiotics in the treatment of active Crohn's disease: experience with metronidazole and ciprofloxacin. Ital J Gastroenterol Hepatol 30, 602-606.
30. Pryde, S. E., Richardson, A. J., Stewart, C. S. & Flint, H. J. (1999). Molecular analysis of the microbial diversity present in the colonic wall, colonic lumen and caecal lumen of a pig. Appl Environ Microbiol 65, 5372-5377.
31. Rath, H. C., Herfarth, H. H., Ikeda, J. S. & 7 other authors (1996). Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human β2 microglobulin transgenic rats. J Clin Invest 98, 945-953.
32. Rath, H. C., Ikeda, J. S., Linde, H. J., Schölmerich, J., Wilson, K. H. & Sartor, R. B. (1999). Varying cecal bacterial loads influences colitis and gastritis in HLA-B27 transgenic rats. Gastroenterology 116, 310-319.
33. Ruseler-van Embden, J. G. & Both-Patoir, H. C. (1983). Anaerobic Gram-negative faecal flora in patients with Crohn's disease and healthy subjects. Antonie van Leeuwenhock 49, 125-132.
34. Rutgeerts, P., Hiele, M., Geboes, K., Peeters, M., Penninckx, F., Arets, R. & Kerremans, R. (1995). Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection. Gastroenterology 108, 1617-1621.
35. Salzman, N. H., de Jong, H., Paterson, Y., Harmsen, H. J. M., Welling, G. W. & Bos, N. A. (2002). Analysis of 16S libraries of mouse gastrointestinal microflora reveals a large new group of mouse intestinal bacteria. Microbiology 148, 3651-3660.
36. Schuppler, M., Mertens, F., Schön, G. & Göbel, U. B. (1995). Molecular characterization of nocardioform actinomycetes in activated sludge by 16S rRNA analysis. Microbiology 141, 513-521.
37. Schuppler, M., Lötzsch, K., Waidmann, M. & Autenrieth, I. B. (2004). An abundance of Escherichia coli is harbored by the mucosa-associated flora of interleukin-2-deficient mice. Infect Immun 72, 1983-1990.
38. Seksik, P., Rigottier-Gois, L., Gramet, G., Sutren, M., Pochart, P., Marteau, P., Rian, R. & Doré, J. (2003). Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon. Gut 52, 237-242.
39. Sellon, R. K., Tonkonogy, S., Schultz, M., Dielemann, L. A., Grenther, W., Ballish, E., Rennick, D. M. & Sartor, R. B. (1998). Resident enteric bacteria arc necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun 66, 5224-5231.
40. Suau, A., Bonnet, R., Sutren, M., Godon, J.-J., Gibson, G. R., Collins, M. D. & Doré, J. (1999). Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Appl Environ Microbiol 65, 4799-4807.
41. Swidsinski, A., Ladhof, A., Pernthaler, A. & 8 other authors (2002). Mucosal flora in inflammatory bowel disease. Gastroenterology 122, 44-54.
42. Tsai, H. H., Sunderland, D., Gibson, G. R., Hart, C. A. & Rhodes, J. M. (1992). A novel mucin sulphatase from human faeces: its identification, purification and characterization. Clin Sci 82, 447-454.
43. Tsai, H. H., Dwarakanath, A. D., Hart, C. A., Milton, J. D. & Rhodes, J. M. (1995). Increased faecal mucin sulphatase activity in ulcerative colitis: a potential target for treatment. Gut 36, 570-576.
44. van Kruiningen, H. J. (1995). On the use of antibiotics in Crohn's disease. J Clin Gastroenterol 20, 310-316.
45. Waidmann, M., Bechtold, O., Frick, J. S., Lehr, H. A., Schubert, S., Dobrindt, U., Loeffler, J., Bohn, E. & Autenrieth, I. B. (2003). Bacteroides vulgatus protects against Escherichia coli-induced colitis in gnotobiotic interleukin-2-deficient mice. Gastroenterology 125, 162-177.
46. Wang, X., Heazlewood, S. P., Krause, D. O. & Florin, T. H. J. (2003). Molecular characterization of the microbial species that colonize human ileal and colonic mucosa by using 16S rDNA sequence analysis. J Appl Microbiol 95, 508-520.
47. Wright, D. P., Rosendale, D. I. & Robertson, A. M. (2000). Prevotella enzymes involved in mucin oligosaccharide degradation and evidence for a small operon of genes expressed during growth on mucin. FEMS Microbiol Lett 190, 73-79.
48. Zoetendal, E. G., von Wright, A., Vilpponen-Salmela, T., Ben-Amor, K., Akkermans, A. D. L. & de Vos, W. M. (2002). Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces. Appl Environ Microbiol 68, 3401-3407.